Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2024-07-11 Board/Management Inform…
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number : 0625W) from Belluscura PLC. The core content explicitly states a 'Directorate Change,' detailing the intention of Non-executive Director Jonathan Satchell to step down from his role. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and serves as a direct announcement, not a comprehensive report.
2024-07-11 English
Result of General Meeting
AGM Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 5382V) on July 8, 2024. The primary content details the 'Result of General Meeting,' specifically confirming that both resolutions put to the meeting were approved by shareholders. This directly relates to the outcome of a shareholder vote. The category 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most precise fit for reporting the results of a General Meeting.
2024-07-08 English
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-07-07 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the RNS Number (2083V) and the header 'Director/PDMR Shareholding'. It details the sale and purchase of ordinary shares by a Non-Executive Director (David Poutney) and persons closely associated with him, including specific transaction dates (3 July 2024), prices, and volumes. This content directly corresponds to the definition of Director's Dealing (insider trades) as per the provided classification list. The filing code for this activity is DIRS.
2024-07-04 English
Conditional placing of unsecured CLNs
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement from Belluscura PLC dated July 2, 2024. The content details a 'Conditional placing of approximately £1.71 million' via convertible loan notes and subscriptions for ordinary shares to raise capital. This clearly falls under financing activities. The definition for 'Capital/Financing Update' (CAP) is 'Updates on company fundraising, financing activities, or capital structure changes.' Although it is distributed via RNS, the primary subject matter is a capital raise, making CAP the most specific and accurate classification over the general RNS fallback. The document length is substantial (over 42k characters), indicating it is the full announcement, not just a brief notice of publication.
2024-07-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement released via RNS (the news service of the London Stock Exchange) on July 1, 2024. The core content is titled "Total Voting Rights" and explicitly states the total number of Ordinary Shares in issue (167,032,567) and clarifies that this figure should be used by shareholders as the denominator for calculating their notification requirements under the FCA's Disclosure Guidance and Transparency Rules. This type of mandatory disclosure regarding the total share capital and voting rights is a standard regulatory filing, but it does not fit neatly into the specific categories like 10-K, ER, or DIV. Since it is a formal regulatory announcement that doesn't match a more specific category, the most appropriate classification is the general regulatory filing fallback, RNS.
2024-07-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.